Skip to main content

Table 1 Known targets of protein kinase inhibitors tested

From: Generation and characterization of a highly effective protein substrate for analysis of FLT3 activity

Inhibitors

Known Targets

Sunitinib

VEGFRs, PDGFRs, KIT, and FLT3

Nilotinib

BCR-ABL, KIT, DDRs, PDGFRs, and CSF-1R

Erlotinib

EGFR and JAK2

Gefitinib

EGFR, Her2, and Her3

Dasatinib

BCR-ABL, SRCs, and KIT

Imatinib

BCR-ABL, KIT, and PDGFRs

Lestaurtinib

FLT3, JAK2, TrkA, TrkB, and TrkC

Sorafenib

B-Raf, C-Raf, PDGFRs, VEGFRs, KIT, and FLT3